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Introduction
Numerous published studies identify acute kidney injury
(AKI) as an independent risk factor for developing inci-
dent chronic kidney disease (CKD), progressive CKD,
end-stage renal disease (ESRD), and other important
non-renal outcomes with substantial public health impli-
cations. A recent meta-analysis showed that use of high-
chloride crystalloids in critically ill patients was asso-
ciated with a significantly higher risk of AKI (1).
Objectives
The objective of this study was to evaluate the cost-effec-
tiveness of using high-chloride vs. low-chloride crystal-
loid fluids in patients hospitalized in the intensive care
unit (ICU) from the US third-party provider perspective.
Methods
A Markov decision model was developed to assess the
overall impact of chronic dialysis progression, both in
survivors of AKI and in patients without AKI exposed
to high-chloride vs. low-chloride crystalloids over the
life time horizon. The model inputs, including costs, uti-
lities, and probabilities, were extracted from the pub-
lished literature. The relative risk of developing AKI was
obtained from the meta-analysis of published rando-
mized clinical trials and observational studies mentioned
above (n= 9 studies with a total of 229 patients). The
model simulated the patient outcomes, assessing the life
years gained (LYG), quality-adjusted life years (QALYs),
and associated health care costs.
Results
The probability of patients developing AKI post fluid
resuscitation with high-chloride crystalloids was 36% vs.
22% for patients receiving low-chloride crystalloids. At
90 days, the risk of patients progressing to chronic dialy-
sis in AKI survivors receiving renal replacement therapy
(RRT) was 88.04 per 100,000 patients in the high-chlor-
ide group vs. 53.68 per 100,000 patients in the low-
chloride group. Overall costs were lower for patients
receiving low-chloride crystalloids, translating into
savings of $2,571 per patient over the lifetime horizon.
The incremental cost-effectiveness ratio (ICER) of
-$3,699 per QALY indicated that low-chloride crystal-
loids dominate (i.e. less costly and more effective) high-
chloride crystalloids and was well below the societal will-
ingness-to-pay threshold of $100,000 in the US. Various
sensitivity analyses confirmed the robustness of these
findings.
Conclusions
In a Markov-based decision model of patients hospitalized
in the intensive care unit, low-chloride crystalloids were
dominant (less costly and more effective) compared to
high-chloride crystalloids. The overall impact on patients
progressing to chronic dialysis and the associated costs
were significantly reduced in survivors of AKI receiving
low-chloride fluid resuscitation.
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